Investor Profile: Anzu Partners — Thesis, Cheque Size & How to Apply

Founders asking how to get funding from Anzu Partners are usually building something hard: industrial machinery, advanced materials, manufacturing tech or life-science platforms. Anzu is a deeptech investment firm with $1 billion in assets under management across venture, private credit and public structures, and a team of 50+ experts — investors, operators, consultants, scientists and engineers — working alongside founders to bring world-changing technologies to market.

Thesis & focus

Anzu invests in breakthrough industrial and life science technologies with the potential to transform their industries — in its own words, “the technologies that enable tomorrow's industries.” The firm pairs capital with deep operational support across business development, market positioning, global connectivity and operations. It invests primarily at the early stage in US and Canada-based private companies, and deliberately looks beyond Silicon Valley: portfolio companies have come from Durham, Omaha and Santa Fe as well as Boston and its surrounding area.

Sectors & stages

Focus areas are clean tech, industrial and life science technologies, spanning next-generation manufacturing to therapy discovery — advanced materials, manufacturing technology, and life-science platforms such as genomics and diagnostics. Stage: early-stage venture, with the firm also running growth-debt and revenue-based vehicles and SPAC structures alongside its venture funds.

Fund size & cheque size

Anzu has raised three venture funds: Fund I at $128 million (closed December 2017), an oversubscribed Fund II at $190 million (closed January 2020 against a $150 million target), and a Fund III that held a first close at $130 million toward a $300 million target in July 2021 — at which point the firm reported roughly $935 million in strategic assets. The firm's site now states $1 billion in assets under management. Cheques run $3 million to $8 million initially, with follow-on commitments of up to $15 million.

Anzu Partners funding: notable portfolio

Portfolio companies include 6K (advanced materials production platform), Niron Magnetics (rare-earth-free magnets), InterVenn Biosciences (cancer diagnostics), BioSkryb (gene sequencing), GelSight (3D imaging for manufacturing quality control), Sofregen (silk-protein tissue products) and Solchroma Technologies (digital displays). Early exits include Axsun Technologies — sold to Excelitas in a roughly $80 million transaction — and MultiMechanics, acquired by Siemens.

Partners & team

The firm was co-founded and is managed by former Boston Consulting Group leadership David Seldin and David Michael, with Whitney Haring-Smith as managing partner; John Ho, PhD is a partner. The investment team is unusually technical — earlier funds staffed six to eight PhDs in technical disciplines — and the firm operates from Boston, San Diego, Tampa and Washington DC.

How to apply for funding

Anzu publishes no pitch-application portal. The realistic route for founders is a warm introduction through the deeptech and industrial network — the firm's partners source heavily from research, engineering and operator circles — or a direct approach through the contact channels on anzupartners.com. Come with technical validation: pilot data, a working prototype or peer-reviewed grounding will carry more weight than a market-size slide.